Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.26.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 21,866,071 $ 3,530,913
General and administrative expenses 6,102,374 8,696,335
Total operating expenses 27,968,445 12,227,248
Loss from operations (27,968,445) (12,227,248)
Other expense:    
Loss on debt conversion with related party (6,134,120)  
Loss on fixed asset disposal (2,731)  
Interest income (expense), net 96,938 (92,192)
Exchange loss, net (27,916) (30,787)
Total other expense (6,067,829) (122,979)
Loss before income taxes (34,036,274) (12,350,227)
Deferred income tax (expense) benefit (221,096) 503
Net loss (34,257,370) (12,349,724)
Accrual of paid-in-kind dividends on Series A Non-Voting Convertible Preferred Stock (1,256,662) (514,105)
Net loss attributable to common stockholders $ (35,514,032) $ (12,863,829)
Net loss per common share, basic (in dollars per share) $ (7.13) $ (12.52)
Net loss per common share, diluted (in dollars per share) $ (7.13) $ (12.52)
Weighted average number of shares outstanding - basic (in shares) 4,977,446 1,027,788
Weighted average number of shares outstanding - diluted (in shares) 4,977,446 1,027,788
Comprehensive loss    
Net loss $ (34,257,370) $ (12,349,724)
Foreign currency translation adjustment 3,275,948 (3,862,987)
Comprehensive loss $ (30,981,422) $ (16,212,711)